Descentralização e expansão dos tratamentos de leishmaniose visceral (LV) com anfotericina B lipossomal em Minas Gerais, 2008-2012

Tourinho, Bruna Dias; Ferraz, Marcela Lencine; Amâncio, Frederico Figueiredo; Carneiro, Mariângela.
Gerais (Esc. Saúde Pública Minas Gerais) ; 4(1): 70-79, jan.-jun 2016.
Artigo Português | Coleciona SUS (Brasil), SES-MG | ID: biblio-945087

Documentos relacionados

  1. Splenectomy for Visceral Leishmaniasis Out of an Endemic Region: A Case Report and Literature Review.
  2. Rational repurposing, synthesis, <i>in vitro</i> and <i>in silico</i> studies of chromone-peptidyl hybrids as potential agents against <i>Leishmania donovani</i>.
  3. Diagnosis of visceral leishmaniasis in Ceará state, Brazil: A flow analysis of cases between 2007 and 2021.
  4. Serological characteristics and clinical implications of IgG subclasses in visceral leishmaniasis.
  5. Observation on Treatment of Drug Resistant Kala-azar Patients with Fungizone in Patna, Bihar.
  6. SHIP1 inhibition via 3-alpha-amino-cholestane enhances protection against Leishmania infection.
  7. New synthetic molecules incorporated into polymeric micelles used for treatment against visceral leishmaniasis.
  8. An algorithm for visceral leishmaniasis diagnosis in Brazil from a 10-year analysis of National Reference Laboratory data.
  9. Evaluating complete surface-associated and secretory proteome of Leishmania donovani for discovering novel vaccines and diagnostic targets.
  10. In vitro antileishmanial activity of thioridazine on amphotericin B unresponsive/ sensitive Leishmania donovani promastigotes and intracellular amastigotes.